Intramuscular injection of nerve growth factor (NGF) into rat masseter muscle induces a 40 local mechanical sensitization that is greater in female than in male rats. The duration of 41 NGF-induced sensitization in male and female rats was associated with an increase in 42 peripheral N-Methyl-D-Aspartate (NMDA) receptor expression by masseter muscle 43 afferent fibers that began 3 days post injection. Here we investigated the functional 44 consequences of increased NMDA expression on the response properties of masseter 45 muscle mechanoreceptors. In vivo extracellular single unit electrophysiological 46 recordings of trigeminal ganglion neurons innervating the masseter muscle were 47 performed in anesthetized rats 3 days after NGF injection (25 µg/ml, 10µl) into the 48 masseter muscle. Mechanical activation threshold was assessed before and after 49 intramuscular injection of NMDA. NMDA injection induced mechanical sensitization in 50 both sexes that was increased significantly following NGF injection in the male rats but 51 not in the female rats. However, in female but not male rats, further examination found 52 that pre-administration of NGF induced a greater sensitization in slow Aδ fibers (2-7 m/s) 53 than fast Aδ fibers (7-12 m/s). This suggests that pre-administration of NGF had a 54 different effect on slowly conducting mechanoreceptors in the female rats compared to 55 the male rats. Although previous studies have found an association between estrogenic 56 tone and NMDA activity, no correlation was observed between NMDA-evoked 57 mechanical sensitization and plasma estrogen level. This study suggests NGF alters 58 NMDA-induced mechanical sensitization in the peripheral endings of masseter 59 mechanoreceptors in a sexually dimorphic manner. 60 3 Keywords 61 Nerve growth factor, Masseter Muscle, Mechanoreceptors, Sensitization, NMDA 62 receptors 63 Rats were anesthetized with isoflurane (AErrane, Baxter Corporation, Mississauga, ON, 132
Introduction 64
Glutamate is the major excitatory neurotransmitter in the central nervous system (Platt 65 2007) . Evidence suggests that it may also play a role in peripheral nociception ( macrophages (Newsholme and Calder 1997) . Glutamate may also be released by the 72 peripheral endings of the primary afferent fibers during nociceptive stimulation and acts 73 on the glutamate receptors on the primary afferent fibers themselves (Westlund et al. 74 1989; deGroot et al. 2000) . This raises the possibility that peripheral glutamate may have 75 an autocrine and/or paracrine role in a positive-feedback enhancement of nociceptor 76 excitability (Lam et al. 2005) . 77 A number of clinical and animal studies have provided behavioral evidence in 78 support of a role for peripheral glutamate receptors in the transduction of masticatory 79 muscle nociceptive signaling. In particular, glutamate concentrations were significantly 80 higher in the masseter muscles of myofascial temporomandibular disorder (TMD) 81 patients when compared to healthy controls (Castrillon et al. 2010 ). Injection into the 82 masseter muscle of healthy subjects induced pain and mechanical sensitization and this 83 response was blocked by a NMDA receptor antagonist (Svensson et al. 2003) . 84
Glutamate-evoked pain was also found to be greater in women than men, similar to the 85 sex-related difference in the occurrence of TMD pain (Cairns and Gazerani 2009 ). In rat 86 5 masseter muscle, baseline interstitial glutamate concentration was found to be ~25 µM 87 and increasing this concentration 2-3 times via systemic injection of monosodium 88 glutamate resulted in a decrease in the mechanical activation threshold of masseter 89 muscle nociceptors (Cairns et al. 2007 ). These results suggest that masseter muscle 90 afferent mechanical sensitivity may be regulated, in part, through peripheral NMDA 91 receptors. 92
The neurotrophin NGF has recently been found to be an important peripheral 93 mediator of nociception. Elevated levels of NGF have been found in many chronic pain 94 conditions (Anand 1995) . Injection of NGF into the masseter muscle of healthy subjects 95 resulted in a local mechanical sensitization that lasted for 1-3 weeks, with a greater 96 magnitude in women than men (Svensson et al. 2003; . In a 97 previous study, we demonstrated that injection of NGF into the rat masseter muscle 98 induced a prolonged local mechanical sensitization, which was also greater in female rats 99 than male rats (Wong et al. 2014 ). The duration of this sensitization was associated with 100 an increased expression of NMDA receptors in masseter muscle afferent fibers, 101 suggesting that NGF-induced sensitization may be maintained by increased peripheral 102
NMDA receptor expression. 103
In the present study, we examined whether pre-administration of NGF alters the 104 response of masseter muscle afferent fibers to peripheral NMDA receptor activation in 105 rats. We also examined whether this effect exhibits a sex-related difference. The results 106 from this study indicate a significant interaction between NGF and the ability of 107 peripheral NMDA receptors to modulate the mechanical sensitivity of masseter muscle 108 afferent fibers. 109 110 6
Methods 111
Animals 112
Male (310-480 g, n=22) and female (230-300 g, n=21) Sprague-Dawley rats were used 113 for the experiments. Animals were housed in groups of two with a 12-h light/dark cycle. 114
Food and water were given ad libitum. All animal procedures were reviewed and 115 approved by the University of British Columbia Animal Care Committee. 116 117
Administration of NGF 118
Intramuscular injection of NGF (25 µg/ml, 10 µl, Sigma) or vehicle (phosphate buffered 119 saline, PBS, 10 µl, Sigma) was injected into the right masseter muscle after the animal 120 was briefly anesthetized with isoflurane (AERrane, Bazter Corporation, Missisauga, ON, 121 Canada; 2-2.5%) and oxygen (97-98%). The experimenter was blinded to the content of 122 the injections. The masseter muscle region was shaved prior to injection and the 123 injection site was marked with a permanent marker for subsequent identification. The 124 concentration of NGF was selected based on the concentration used in previous human 125 experimental pain studies and acute experiments in rats (Svensson et al. 2003 was inserted to ventilate the animal throughout the experiment and body temperature was 135 maintained at 37.0 ± 0.2 °C with an electric heating pad controlled from a rectal 136 thermometer. The heart rate and blood pressure were monitored throughout the 137 experiment. The hair of the right side of the face was shaved before the animal's head 138 was positioned in a stereotaxic frame. An incision was made to the skin over the dorsal 139 surface of the skull to expose the skull bone and a small trephination was made in the 140 bone to allow lowering of a microelectrode through the brain into the trigeminal ganglion 141 for recording. An incision was also made to the skin over the neck to expose the 142 brainstem and the dura was removed to allow a stimulating electrode to contact the 143 brainstem. Animals were euthanized at the end of the experiments (100 mg/kg; 144 Nembutal, Abbott Laboratories, Chicago, IL, USA). 145 146
In vivo electrophysiological recording 147
In vivo extracellular single unit recording was performed 3 days after NGF injection, 148 which was previously found to be the time of peak NGF-induced NMDA receptor 149 upregulation (Wong et al. 2014 ). Extracellular action potentials of masseter ganglion 150 neurons were recorded with a parylene-coated tungsten microelectrode (0.10", 2MΩ, A-151 M Systems Inc., Carlsborg, WA, USA). Mechanoreceptors innervating the masseter 152 muscle were identified by their response to mechanical stimulation applied to the muscle 153 with a fine-tipped cotton swab. The mechanoreceptive field of the afferent fiber was 154 confirmed to be in the muscle if the fiber did not respond to mechanical stimulation of the 155 overlying skin and the jaw but did respond to insertion of a catheter needle (to deliver 156 8 NMDA) into the masseter muscle. The skin over the mechanoreceptive field was marked 157 with permanent marker. The distance between the initial NGF injection site and the 158 mechanoreceptive field of the fiber was measured at the end of the recording session. 159
Antidromic collision was performed to confirm projection of the masseter muscle 160 fiber to the caudal brain stem. A stimulating electrode (parylene-coated tungsten 161 microelectrode, 0.10", 2MΩ, A-M Systems Inc., Carlsborg, WA, USA) was lowered into 162 the ipsilateral caudal brainstem and a constant-current electrical stimulus (100 µs 163 biphasic pulse, 10-90 µA, 0.5 Hz) was applied to evoke antidromic action potentials. 164
Orthodromic action potentials were evoked by mechanical stimulation of the masseter 165 muscle. Collision was demonstrated by disappearance of the antidromic spike ( Figure  166 1A). The straight line distance between the stimulating and recording electrodes was 167 divided by latency of the antidromic action potential to estimate conduction velocity. 168
Mechanical activation threshold was assessed with an electronic von Frey hair 169 (model 1601C, Life Science, Woodland Hills, CA, USA). Mechanical stimuli were 170 applied to the receptive field of the fiber at 1 min intervals for 10 min to obtain a baseline 171 threshold (minimum force required to evoke afferent discharge, Figure 1B ). Force was 172 increased gradually until a response was observed ( Figure 1B ). After baseline recording, 173 a 26-gauge needle connected to a 25 μl Hamilton syringe (Hamilton, Reno, NV, USA) 174 via a polyethylene tube that contained NMDA was inserted into the mechanoreceptive 175 field of the masseter muscle afferent fiber. A ten-minute recording period followed to 176 record any baseline spontaneous discharge. After this baseline measurement, a single 177 injection of NMDA (500 mM, 10 µl, pH 7.4) was administered to assess whether NGF 178 alters response of masseter afferents to chemical stimulation. This was followed by a 179 9 ten-minute recording period to assess NMDA-evoked discharge. Mechanical activation 180 threshold was then reassessed at the end of this period for 10 minutes in the same manner 181 as described for baseline measurement. It was occasionally possible to record from more 182 than one muscle afferent fiber in the same animal. This occurred in male rats for the 183 vehicle group (12 afferent fibers from 10 animals) and in female rats in both the vehicle 184 (12 afferent fibers from 11 animals) and NGF group (12 afferent fibers from 10 animals). Results 211
Mechanical activation threshold 212
Before NMDA injection, no significant difference was observed in the mean 213 baseline mechanical activation thresholds between the vehicle (n=12) and NGF groups 214 (n=12) in male (vehicle, 30.5 ± 9.3 g; NGF, 32.3 ± 8.2 g) or female rats (vehicle, 34.2 ± 215 9.6g; NGF, 41.9 ± 11.1 g). The baseline mechanical activation thresholds were plotted 216 against conduction velocities of the afferent fibers ( Figure 2) . A significant inverse 217 correlation between conduction velocity and mechanical activation threshold was 218 observed in the vehicle group of the male rats (coefficient = -0.776) but not in the female 219 rats, which is consistent with a previous study (Mann et al 2006). However, a significant 220 inverse correlation (coefficient = -0.685) between conduction velocity and mechanical 221 activation threshold was found in the NGF-treated female rats. In Figure 2 , the lines 222 represent masseter mechanical withdrawal thresholds determined from an earlier 223 behavioral study in male and female rats at 3 days after intramuscular injections of 224 vehicle or NGF into the masseter muscle (Wong et al 2014) . The injection procedure 225 (vehicle, NGF concentration and injection volume) in that study was identical to the one 226 11 in this study. The electronic von Frey hair used to determine the mechanical withdrawal 227 thresholds was also from the same manufacturer (IITC) as the one employed here. 228
Afferent fibers with mechanical activation thresholds above the respective line (vehicle 229 or NGF treatment) were considered to be putative mechano-nociceptors. The number of 230 masseter afferent fibers with a mechanical activation threshold above the withdrawal 231 threshold was found to be 3/12 in the vehicle group and 5/12 in the NGF group in the 232 male rats, while a bigger difference was found between the vehicle (3/12) and NGF 233 groups (7/12) in the female rats. None of the differences reached statistical significance 234 (Fisher's exact test, p>0.05). 235
NMDA injection significantly reduced mechanical activation threshold in all 236 treatment groups when compared to the baseline MT in male (vehicle, 25.4 ± 8g; NGF, 237 21 ± 7.1 g) and female rats (vehicle, 27.7 ± 7.9 g; NGF, 30.7 ± 10.3 g). In the male rats, 238 NMDA-induced mechanical sensitization was significantly greater in the NGF group than 239 the vehicle group (Figure 3 A & B) . In female rats, NMDA-induced mechanical 240 sensitization was increased in the NGF group, however, the difference was not significant 241 (p>0.05). The relationship between conduction velocity and Rel MT is presented in 242 The number of spontaneous discharges and NMDA-evoked discharges were evaluated 265 over a ten-minute period before and after NMDA injection. No difference in the 266 proportion of afferent fibers with spontaneous discharges before and after NMDA 267 injection was found between the vehicle and NGF treatment groups in either sex (Table  268 1). NGF treatment also had no effect on the frequency of spontaneous discharges before 269 and after NMDA injection (Table 2) . 270
271
Distance 272
Since the masseter fibers were randomly identified through mechanical stimulation of the 273 masseter muscle, one possible confounding factor could be the distance between the 274 initial NGF injection and the mechanoreceptive field of the recorded fiber ( Figure 5A ). 275
To determine whether this distance affected the results, the distance between the initial 276 NGF injection and the subsequent NMDA injection for the NGF treatment group is 277 plotted against Baseline MT and Rel MT ( Figure 5B & C) . No correlation was observed, 278 demonstrating that the distance between NGF injection and the mechanoreceptive field of 279 the fiber did not affect the subsequent mechanical sensitization. 280 281 14 Discussion 282 NGF is an important mediator of pain and elevated levels have been found in many 283 chronic pain conditions (Anand 1995) . Intramuscular injection of NGF into the masseter 284 muscle induced a long lasting local mechanical sensitization in humans, which was 285 mimicked by equivalent injections into the rat masseter muscles, suggesting that this 286 could be a valuable animal model for investigating the mechanism of NGF-induced with an increased expression of NR2B subunit containing NMDA receptors in masseter 290 ganglion neurons in both male and female rats and was partly attenuated by an 291 intramuscular injection of the NMDA receptor antagonist, 2-amino-5-phosphonvalerate, 292 three days after NGF injection, in the male rats (Wong et al. 2014 ). In the present study, 293 we examined whether NGF alters the response of individual masseter mechanoreceptors 294 to peripheral NMDA receptor activation. NGF increased the level of mechanical 295 sensitization in masseter muscle afferent fibers after local injection of NMDA into the 296 masseter muscle, suggesting the effect of NGF occurs in the peripheral endings of muscle 297 afferents. Taken together, these results suggest that a peripheral mechanism whereby 298 NGF induces local mechanical sensitization by increasing the expression of NMDA 299 receptors at the peripheral endings of masseter mechanoreceptors, underlies the 300 sensitization produced by NGF injections in rats at 3 days after NGF injection. 301 302 Intramuscular injection of NMDA has been shown to evoke discharges in 303 masseter muscle mechanoreceptors and increasing the expression of NMDA receptors by 304 15 estrogen treatment has been shown to increase the magnitude of this discharge (Dong et 305 al. 2007; McRoberts et al. 2007 ). Since we previously found NGF increases expression 306 of NMDA receptors in masseter muscle ganglion neurons, we would predict that a greater 307 number of NMDA receptors would result in an increase in NMDA-evoked discharges 308 (Wong et al. 2014 ). However, that was not the case, as NGF had no effect on the 309 proportion of fibers with discharges or the magnitude of the discharges after NMDA 310 injection. Interestingly, this result agrees with an earlier human pain experiment where 311 pre-injection of NGF had no effect on the intensity of glutamate-evoked masseter muscle 312 pain in healthy humans ). Further, intramuscular injections of NGF 313 into the masseter muscles of healthy men and women resulted in a prolonged (7-14 day) 314 localized mechanical sensitization without reports of spontaneous pain (Svensson et al. 315 2003; ). Here we found that NGF increased NMDA-induced 316 mechanical sensitization but had no effect on the frequency of spontaneous discharges. 317
These results suggest that NGF does not cause spontaneous pain but may modulate 318 mechanical sensitivity in putative masseter nociceptors by increasing the expression of 319 peripheral NMDA receptors. 320 321 Previous human and rat behavioral experiments found that NGF reduced 322 mechanical thresholds after intramuscular injection into the masseter muscle (Svensson et 323 al. 2003; Wong et al. 2014) . In this study, however, the mean 324 mechanical threshold of masseter afferent fibers did not change after NGF injection. This 325 may be due to the sample size not being large enough to demonstrate this effect since 326 single fibers were randomly identified, encompassing a large range of mechanical 327 16 thresholds. In the vehicle-injected groups, subsequent NMDA injections induced a 328 decrease in mechanical threshold that was comparable to glutamate-induced mechanical 329 sensitization observed in previous studies (Cairns et al. 2002; Cairns et al. 2003) . No 330 difference was found between the male and female rats, which is also consistent with 331 mechanical sensitization induced by glutamate (Cairns et al. 2002) . NMDA induced a 332 greater mechanical sensitization in NGF-treated masseter muscles than the vehicle-333 treated group in the male rats. This is in contrast to an earlier human pain study where 334 pre-injection with NGF did not result in greater glutamate-induced mechanical 335 sensitization of the masseter muscle . However, in that study 336 glutamate was given one day after NGF treatment compared to three days later in the 337 current study. This may be significant since a prior study in the rat found that significant 338 increases in NMDA receptor expression began 3 days after NGF injection (Wong et al. 339 2014) . Our results suggest that NGF increased NMDA-evoked mechanical sensitization 340 by increasing the expression of NMDA receptors in the peripheral endings of masseter 341 nociceptors. However, we cannot exclude the possibility that NGF may also alter the In this study, a sex-related difference was observed in the level of NMDA-evoked 346 mechanical sensitization following NGF injection, with the male rats exhibiting a greater 347 decrease in afferent mechanical threshold than the females. Further examination found 348 that NGF induced a greater NMDA-induced mechanical sensitization in the slow A 349 fibers than fast A fibers in the female rats, but not male rats. This result suggests that 350 NGF may have a different sensitizing effect on putative mechano-nociceptors in the 351 female rats compared to the male rats. This effect was not related to estrogen as no 352 correlation was observed between plasma estrogen concentration and the level of 353 sensitization, although previously it has been found that estrogen may increase masseter 354 NMDA did not evoke SP release in one in vivo study (Navarian et al. 2008 ) and NMDA 374 was found to decrease EPSPs recorded in spinal cord slices in another (Bardoni et al. 375 2004) . The interpretation of these results is not straightforward as activation of 376 presynaptic glutamate receptors may shunt the action potential propagation and reduce 377 neurotransmitter release, a mechanism similar to the proposed role of GABA A receptors 378 in primary afferent depolarization (Bardoni 2013 It is also likely that sex-related differences in NGF-induced mechanical 383 sensitization of the masseter muscle result from a mechanism other than increased 384 peripheral NMDA receptor expression. For example, we previously reported that 385 intramuscular injection of NGF increased the expression of the neuropeptides substance P 386 (SP) and calcitonin gene related peptide (CGRP) by masseter ganglion neurons that co-387 expressed NMDA receptors, but only in female rats (Wong et al. 2014 ). However, 388 peripheral NMDA receptor induced mechanical sensitization of masticatory muscle 389 afferent fibers in female rats is not inhibited by local injections of antagonists for SP or 390 the masseter muscle afferent fiber was projected to the caudal brainstem, antidromic 526 action potential (*) generated by a stimulating electrode in the caudal brainstem was 527 collided with the orthodromic action potential generated by stimulation of the muscle. 528
The conduction velocity of this masseter muscle fiber from a male rat is 10.5 m/s (B) An 529 example of MT measurement is shown. An electronic von Frey hair was used to apply 530 force to the masseter muscle (lower trace) until an action potential was generated in the 531 masseter muscle afferent fiber (upper trace). The arrow indicates the MT for this fiber. 532
The MT of this masseter muscle fiber from a female rat is 34.5 g. 533 The scatter plots show the relationship between this distance (mm) and the baseline MT 566 (B) or Rel MT (C) of masseter mechanoreceptors at 10 min following NMDA injection in 567 27 male and female rats. No significant correlations were identified (Spearman's correlation 568 coefficient, p>0.05) 569
